Dynavax Technologies Corp’s recently made public that its President & COO Novack David F unloaded Company’s shares for reported $0.14 million on Mar 24 ’25. In the deal valued at $14.00 per share,10,000 shares were sold. As a result of this transaction, Novack David F now holds 8,078 shares worth roughly $82153.26.
Then, DAVID NOVACK bought 10,000 shares, generating $140,000 in total proceeds.
Before that, Novack David F sold 14,020 shares. Dynavax Technologies Corp shares valued at $190,392 were divested by the President & COO at a price of $13.58 per share. As a result of the transaction, Novack David F now holds 8,078 shares, worth roughly $82153.26.
Goldman downgraded its Dynavax Technologies Corp [DVAX] rating to a Sell from a a Neutral in a research note published on February 11, 2025; the price target was decreased to $12 from $15. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early February with a ‘”a Neutral”‘ rating. JMP Securities began covering DVAX with “Mkt outperform” recommendation on September 27, 2022.
Price Performance Review of DVAX
On Monday, Dynavax Technologies Corp [NASDAQ:DVAX] saw its stock fall -0.97% to $10.17. Over the last five days, the stock has lost -1.07%. Dynavax Technologies Corp shares have fallen nearly -20.36% since the year began. Nevertheless, the stocks have fallen -15.95% over the past one year. While a 52-week high of $14.63 was reached on 03/07/25, a 52-week low of $9.22 was recorded on 05/14/25.
Levels Of Support And Resistance For DVAX Stock
The 24-hour chart illustrates a support level at 10.06, which if violated will result in even more drops to 9.94. On the upside, there is a resistance level at 10.37. A further resistance level may holdings at 10.56.
The most recent change occurred on August 06, 2021 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $19 price target.
